London Daily

Focus on the big picture.
Wednesday, Jul 16, 2025

Russian 'vaccine tourists' travel to Serbia for Pfizer shot

Russian 'vaccine tourists' travel to Serbia for Pfizer shot

Russian businessman Pavel Grigoriev and his wife are filling out forms at a vaccination centre housed in a huge exhibition hall in Belgrade, some 1,700 kilometres (,1060 miles) from their home in Moscow.
The couple has come all this way to get the Pfizer COVID-19 vaccine because it, unlike the four vaccines on offer in Russia, is approved by the World Health Organisation and the European Union.

"We have decided to get the Pfizer vaccine because, we think, it will allow us more frequent travels to Europe," the 50-year-old Grigoriev said.

Russia's Sputnik V COVID-19 vaccine, used in over 70 other states, has yet to be approved by the WHO, and no foreign-made vaccines have been approved in Russia.

Grigoriev and his wife are part of a new phenomenon which, much to the delight of the local tourism industry, first emerged in Serbia after it launched its COVID-19 inoculation campaign last December.

While countries across the Balkans struggled with hold-ups and shortages, Serbia was trumpeting its success at securing vaccines from a clutch of different suppliers, prompting an influx of 'vaccine tourists'.

Serbia approved vaccines made by Pfizer/BioNtech (PFE.N), (22UAy.DE), China's Sinopharm, AstraZeneca/Oxford (AZN.L) and Russia's Sputnik V for its inoculation programme, but so far only around 50% of Serbia's population received two shots, mainly due to strong anti-vaccine sentiment.

However, many foreigners, including Russians, have flocked to the Balkan country for a shot this year. According to official data, around 160,000 foreigners, mainly from the Balkans, have so far received their COVID-19 vaccines in Serbia.

Local and Russian tourist agencies reeling from the effects of the pandemic, sought to profit from vaccination tourism, said Predrag Tesic, owner of the Belgrade-based BTF agency.

"There are many businessmen among them (Russians) and they must get a vaccine to travel," he said.

A three- or four-day of stay in Belgrade would cost a Russian visitor between 500$ and 700$, Tesic said.

Russian firm Petrovax has said it requested approval for a vaccine manufactured by Sinopharm, although a decision has yet to be made. The Russian health ministry did not respond to a request for comment on whether other foreign manufacturers have submitted requests for approval.

Earlier this month, the Russian health minister said there were enough free vaccines available in Russia.
Newsletter

Related Articles

0:00
0:00
Close
Dimon Warns on Fed Independence as Trump Administration Eyes Powell’s Succession
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
Hungary's Viktor Orban Rejects Agreements on Illegal Migration
Jeff Bezos Considers Purchasing Condé Nast as a Wedding Gift
Ghislaine Maxwell Says She’s Ready to Testify Before Congress on Epstein’s Criminal Empire
Bal des Pompiers: A Celebration of Community and Firefighter Culture in France
FBI Chief Kash Patel Denies Resignation Speculations Amid Epstein List Controversy
Air India Pilot’s Mental Health Records Under Scrutiny
Google Secures Windsurf AI Coding Team in $2.4 Billion Licence Deal
Jamie Dimon Warns Europe Is Losing Global Competitiveness and Flags Market Complacency
South African Police Minister Suspended Amid Organised Crime Allegations
Nvidia CEO Claims Chinese Military Reluctance to Use US AI Technology
Hong Kong Advances Digital Asset Strategy to Address Economic Challenges
Australia Rules Out Pre‑commitment of Troops, Reinforces Defence Posture Amid US‑China Tensions
Martha Wells Says Humanity Still Far from True Artificial Intelligence
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
U.S. Resumes Deportations to Third Countries After Supreme Court Ruling
Excavation Begins at Site of Mass Grave for Children at Former Irish Institution
Iranian President Reportedly Injured During Israeli Strike on Secret Facility
EU Delays Retaliatory Tariffs Amid New U.S. Threats on Imports
Trump Defends Attorney General Pam Bondi Amid Epstein Memo Backlash
Renault Shares Drop as CEO Luca de Meo Announces Departure Amid Reports of Move to Kering
Senior Aides for King Charles and Prince Harry Hold Secret Peace Summit
Anti‑Semitism ‘Normalised’ in Middle‑Class Britain, Says Commission Co‑Chair
King Charles Meets David Beckham at Chelsea Flower Show
If the Department is Really About Justice: Ghislaine Maxwell Should Be Freed Now
NYC Candidate Zohran Mamdani’s ‘Antifada’ Remarks Spark National Debate on Political Language and Economic Policy
President Trump Visits Flood-Ravaged Texas, Praises Community Strength and First Responders
From Mystery to Meltdown, Crisis Within the Trump Administration: Epstein Files Ignite A Deepening Rift at the Highest Levels of Government Reveals Chaos, Leaks, and Growing MAGA Backlash
Trump Slams Putin Over War Death Toll, Teases Major Russia Announcement
Reparations argument crushed
Rainmaker CEO Says Cloud Seeding Paused Before Deadly Texas Floods
A 92-year-old woman, who felt she doesn't belong in a nursing home, escaped the death-camp by climbing a gate nearly 8 ft tall
French Journalist Acquitted in Controversial Case Involving Brigitte Macron
Elon Musk’s xAI Targets $200 Billion Valuation in New Fundraising Round
Kraft Heinz Considers Splitting Off Grocery Division Amid Strategic Review
Trump Proposes Supplying Arms to Ukraine Through NATO Allies
EU Proposes New Tax on Large Companies to Boost Budget
Trump Imposes 35% Tariffs on Canadian Imports Amid Trade Tensions
Junior Doctors in the UK Prepare for Five-Day Strike Over Pay Disputes
US Opens First Rare Earth Mine in Over 70 Years in Wyoming
Kurdistan Workers Party Takes Symbolic Step Towards Peace in Northern Iraq
Bitcoin Reaches New Milestone of $116,000
Biden’s Doctor Pleads the Fifth to Avoid Self-Incrimination on President’s Medical Fitness
Grok Chatbot Faces International Backlash for Antisemitic Content
Severe Heatwave Claims 2,300 Lives Across Europe
NVIDIA Achieves Historic Milestone as First Company Valued at $4 Trillion
Declining Beer Consumption Signals Cultural Shift in Germany
Linda Yaccarino Steps Down as CEO of X After Two Years
×